Effect of Celergen, a marine derivative, on in vitro hepatocarcinogenesis

Area of Science:

• Marine Biology
• Cancer Research
• Molecular Biology

Background:

• Hepatocellular carcinoma (HCC) remains a significant global health challenge.
• Developing novel chemopreventive agents is crucial for cancer management.
• Celergen, a marine-derived compound, is being investigated for its therapeutic potential.

Purpose of the Study:

• To evaluate the anticarcinogenic effects of Celergen on the HepG2 human liver cancer cell line.
• To assess Celergen's impact on cancer cell proliferation, cell cycle, and apoptosis.
• To explore the molecular mechanisms underlying Celergen's potential chemopreventive properties.

Main Methods:

• HepG2 cells were treated with varying concentrations of Celergen.
• Cell proliferation was assessed using standard assays.
• Cell cycle progression and apoptosis were analyzed via flow cytometry.
• Gene expression levels of p21(CIPl1WAF1), GADD153, and c-myc were quantified.

Main Results:

• Celergen significantly inhibited HepG2 cell proliferation in a dose-dependent manner.
• Celergen treatment led to cell cycle arrest at the G1 phase.
• Significant induction of apoptosis was observed in Celergen-treated cells.
• Celergen upregulated p21(CIPl1WAF1) and GADD153 gene expression while downregulating c-myc.

Conclusions:

• Celergen demonstrates promising chemopreventive properties against liver cancer.
• The compound effectively inhibits cancer cell proliferation and induces apoptosis.
• Molecular changes in p21, GADD153, and c-myc suggest a role in Celergen's mechanism of action.
• Further research is warranted to explore Celergen's therapeutic potential in vivo.